Camelia Iancu-Rubin, PhD

Dr. Iancu-Rubin completed her Bachelor and Master degrees in biology at the University of Bucharest in Romania. She started her career in clinical laboratory and teaching then pursued graduate studies in Biomedical Sciences as Fulbright Scholar. Dr. Iancu-Rubin received her PhD Summa Cum Laude from the University of Bucharest and completed a 5-year postdoctoral fellowship in the Division of Hematology at the Mount Sinai Medical Center in New York. She is currently a Professor in the Department of Pathology, Molecular and Cell-Based Medicine and member of the Tisch Cancer Institute at Icahn School of Medicine at Mount Sinai. Dr. Iancu-Rubin has been leading investigator on NIH-funded, foundations and institutional projects as well as on industry-sponsored studies. Her research focuses on preclinical and clinical development of hematopoietic stem cell-based therapies for patients with blood disorders. Dr. Iancu-Rubin is the Director of the Cellular Therapy Laboratory which supports hematopoietic stem cells transplantation services and other cell-based therapies at Mount Sinai Hospital.